The down-regulation of ROCK can reduce cardiac fibrosis11, and specific deletion of ROCK2 in fibroblasts can alleviate cardiac hypertrophy, fibrosis and diastolic dysfunction through inhibiting the production of fibroblast growth factor (FGF)12. Here, FGF12 is linked to cardiac hypertrophy.